In the wake of the multitude of recalls in 2005 of implantable systems - primarily pacemakers and implantable cardioverter defibrillators - the FDA's Center for Devices and Radiological Health in January unveiled an intensified effort for the post-market surveillance and reporting of problems with all medical devices.